Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
2000 2
2001 1
2002 1
2003 2
2004 1
2005 60
2006 41
2007 43
2008 42
2009 61
2010 63
2011 65
2012 67
2013 82
2014 95
2015 107
2016 81
2017 105
2018 116
2019 112
2020 138
2021 159
2022 68
Text availability
Article attribute
Article type
Publication date

Search Results

1,310 results
Results by year
Filters applied: . Clear all
Page 1
Chronic Inflammatory Demyelinating Polyneuropathy.
Kuwabara S, Misawa S. Kuwabara S, et al. Adv Exp Med Biol. 2019;1190:333-343. doi: 10.1007/978-981-32-9636-7_21. Adv Exp Med Biol. 2019. PMID: 31760654 Review.
Chronic inflammatory demyelinating polyneuropathy (CIDP) is immune-mediated neuropathy defined by clinical progression for more than 2 months, and electrodiagnostic evidence of peripheral nerve demyelination. However, there are several clinical phenoty
Chronic inflammatory demyelinating polyneuropathy (CIDP) is immune-mediated neuropathy defined by clinical progr
Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment.
Lehmann HC, Burke D, Kuwabara S. Lehmann HC, et al. J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):981-987. doi: 10.1136/jnnp-2019-320314. Epub 2019 Apr 16. J Neurol Neurosurg Psychiatry. 2019. PMID: 30992333 Review.
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neuropathy typically characterised by symmetrical involvement, and proximal as well as distal muscle weakness (typical CIDP). However, there are several 'atypical' subtypes,
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neuropathy typically characterise
Rituximab in refractory chronic inflammatory demyelinating polyneuropathy.
Muley SA, Jacobsen B, Parry G, Usman U, Ortega E, Walk D, Allen J, Pasnoor M, Varon M, Dimachkie MM. Muley SA, et al. Muscle Nerve. 2020 May;61(5):575-579. doi: 10.1002/mus.26804. Epub 2020 Jan 21. Muscle Nerve. 2020. PMID: 31922613
INTRODUCTION: Chronic inflammatory demyelinating polyneuropathy (CIDP) is a disorder in which early effective treatment is important to minimize disability from axonal degeneration. ...METHODS: Baseline and post-rituximab-therapy neuromuscular Medical …
INTRODUCTION: Chronic inflammatory demyelinating polyneuropathy (CIDP) is a disorder in which early effective tr …
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
Oo WM, Giri P, de Souza A. Oo WM, et al. J Neuroimmunol. 2021 Nov 15;360:577719. doi: 10.1016/j.jneuroim.2021.577719. Epub 2021 Sep 17. J Neuroimmunol. 2021. PMID: 34560365 Free PMC article. Review.
Covid-19 has been linked with the development of Guillain-Barre Syndrome (GBS), a rare immune-mediated demyelinating neuropathy. We report three cases of Guillain-Barre Syndrome and one case of Chronic Inflammatory Demyelinating Polyneuropathy ( …
Covid-19 has been linked with the development of Guillain-Barre Syndrome (GBS), a rare immune-mediated demyelinating neuropathy. We r …
Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?
Allen JA, Gelinas DF, Freimer M, Runken MC, Wolfe GI. Allen JA, et al. J Neurol Sci. 2020 Jan 15;408:116497. doi: 10.1016/j.jns.2019.116497. Epub 2019 Nov 9. J Neurol Sci. 2020. PMID: 31765922 Free article. Review.
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired neurological disorder characterized clinically by weakness and impaired sensory function evolving over 2 months or more, loss or significant decrease in deep tendon reflexes, and b
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired neurological disorder characterized clin
Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health.
Ryan M, Ryan SJ. Ryan M, et al. Am J Manag Care. 2018 Sep;24(17 Suppl):S371-S379. Am J Manag Care. 2018. PMID: 30312032 Free article. Review.
First described almost 50 years ago, chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder characterized by progressive peripheral neuropathy. ...
First described almost 50 years ago, chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmu …
The Misdiagnosis of CIDP: A Review.
Allen JA. Allen JA. Neurol Ther. 2020 Jun;9(1):43-54. doi: 10.1007/s40120-020-00184-6. Epub 2020 Mar 26. Neurol Ther. 2020. PMID: 32219701 Free PMC article. Review.
There is a growing realization that many patients are incorrectly diagnosed with chronic inflammatory demyelinating polyneuropathy (CIDP), with at least half of patients that carry a diagnosis of CIDP in the USA possibly having a different explanation …
There is a growing realization that many patients are incorrectly diagnosed with chronic inflammatory demyelinating
New evidence for secondary axonal degeneration in demyelinating neuropathies.
Moss KR, Bopp TS, Johnson AE, Höke A. Moss KR, et al. Neurosci Lett. 2021 Jan 23;744:135595. doi: 10.1016/j.neulet.2020.135595. Epub 2020 Dec 24. Neurosci Lett. 2021. PMID: 33359733 Free PMC article. Review.
The intermediate steps between the loss of these functions and the initiation of axon degeneration are unknown but the importance of these processes provides insightful clues. Prevalent demyelinating diseases of the PNS include the inherited neuropathies Charcot-Marie-Toot …
The intermediate steps between the loss of these functions and the initiation of axon degeneration are unknown but the importance of these p …
Resistance training and aerobic training improve muscle strength and aerobic capacity in chronic inflammatory demyelinating polyneuropathy.
Markvardsen LH, Overgaard K, Heje K, Sindrup SH, Christiansen I, Vissing J, Andersen H. Markvardsen LH, et al. Muscle Nerve. 2018 Jan;57(1):70-76. doi: 10.1002/mus.25652. Epub 2017 Apr 15. Muscle Nerve. 2018. PMID: 28345260
INTRODUCTION: We investigated the effects of aerobic and resistance exercise in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). METHODS: Eighteen CIDP patients treated with subcutaneous immunoglobulin performed 12 weeks of aerob …
INTRODUCTION: We investigated the effects of aerobic and resistance exercise in patients with chronic inflammatory demyelin
Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
Kira JI. Kira JI. Front Neurol. 2021 Jun 10;12:665136. doi: 10.3389/fneur.2021.665136. eCollection 2021. Front Neurol. 2021. PMID: 34177770 Free PMC article. Review.
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated demyelinating disease of the peripheral nervous system (PNS). ...Such cases showing demyelinating lesions in both the CNS and PNS are now termed combined centr
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated demyelinating disease of t
1,310 results